Annual report pursuant to section 13 and 15(d)

Document and Entity Information

v2.4.0.6
Document and Entity Information (USD $)
12 Months Ended
Sep. 30, 2011
Jan. 13, 2012
Mar. 31, 2011
Document And Entity Information      
Entity Registrant Name OHR PHARMACEUTICAL INC    
Entity Central Index Key 0001173281    
Document Type 10-K    
Document Period End Date Sep. 30, 2011    
Amendment Flag true    
Amendment Description

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 10-K/A amends and restates in its entirety the Annual Report on Form 10-K for the period ended September 30, 2011 (the “Original Report”) and is being filed by Ohr Pharmaceutical, Inc. (the “Company”) to correct certain inadvertent errors that occurred in the filing of the Original Report.

On January 13, 2012, management became aware of a footing error in the Company’s statement of stockholders’ equity (deficit) in the previously filed Form 10-K for the period ended September 30, 2011.  The error relates to 572,021 shares of Series B preferred stock that were erroneously recorded as outstanding as of September 30, 2006.  As shown in the statement, these shares were in fact convertible preferred shares and were duplicated in the incorrect column.  This error is then footed throughout the table resulting in an ending balance in Series B preferred stock of 6,155,357.  The correct balance is 5,583,336 and is corrected in this Form 10-K/A.   The Company made no other changes in the Annual Report on Form 10-K.

The Company evaluated this error determined that an amendment and restatement of the Form 10-K for the aforementioned annual period is necessary and required.  

Unless expressly noted otherwise, the disclosures in this Form 10-K/A continue to speak as of the date of the Original Report, and do not reflect events occurring after the filing of the Original Report.   The filing of this Form 10-K/A shall not be deemed an admission that the Original Report, when made, included any untrue statement of a material fact or omitted to state a material fact necessary to make a statement not misleading.

   
Current Fiscal Year End Date --09-30    
Is Entity a Well-known Seasoned Issuer? No    
Is Entity a Voluntary Filer? No    
Is Entity's Reporting Status Current? Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 8,809,796
Entity Common Stock, Shares Outstanding   41,535,922  
Document Fiscal Year Focus 2011    
[DocumentFiscalPeriodFocus] FY